Status:
UNKNOWN
Association Between Serum Ferritin Level and Severity of Liver Disease and Development of HCC in Cirrhotic Patients
Lead Sponsor:
Assiut University
Conditions:
HCC
Eligibility:
All Genders
18-75 years
Brief Summary
Association between serum ferritin level and severity of liver disease and development of HCC in cirrhotic patients .
Detailed Description
th leading cause of cancer mortality worldwide, with an estimated 841,000 (9.3 cases per 100,000 person-years) and 782,000 deaths (8.5 deaths per 100,000 person-years) in 2018.(Bray F et al., 2018) In...
Eligibility Criteria
Inclusion
- Patients with liver cirrhosis of both sexes with and without HCC regardless of the aetiology of chronic liver disease
Exclusion
- Patients less than 18 years Previously treated HCC patients with no evidence of recurrence or residual activity Subjects who had received blood transfusions or iron supplements during the previous 3 months.
- Other conditions associated with elevated serum ferritin e.g., malignancy other than HCC, iron overload syndromes, autoimmune disorders, chronic excess alcohol consumption and acute and chronic infections.
- Patients who will refuse to give a written consent, will be excluded from our study
Key Trial Info
Start Date :
August 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2023
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT05401890
Start Date
August 1 2022
End Date
October 1 2023
Last Update
July 26 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.